Pages that link to "Q73416544"
The following pages link to Methylation of the p15(INK4B) gene in myelodysplastic syndrome: it can be detected early at diagnosis or during disease progression and is highly associated with leukaemic transformation (Q73416544):
Displaying 50 items.
- Engineering mouse models with myelodysplastic syndrome human candidate genes; how relevant are they? (Q26828777) (← links)
- Preferential expression of the transcription coactivator HTIF1alpha gene in acute myeloid leukemia and MDS-related AML (Q28216383) (← links)
- DNA methylation predicts survival and response to therapy in patients with myelodysplastic syndromes (Q33628772) (← links)
- Epigenetic changes in the myelodysplastic syndrome. (Q33767309) (← links)
- Myeloid-specific inactivation of p15Ink4b results in monocytosis and predisposition to myeloid leukemia (Q34074925) (← links)
- Chromosome and molecular abnormalities in myelodysplastic syndromes (Q34336409) (← links)
- The role of azacitidine in the management of myelodysplastic syndromes (MDS). (Q34418429) (← links)
- DNA Methylation Changes Following 5-azacitidine Treatment in Patients with Myelodysplastic Syndrome (Q34539944) (← links)
- Tumor suppressor genes in normal and malignant hematopoiesis (Q34658581) (← links)
- Alterations of DNA methylation in hematologic malignancies (Q34762188) (← links)
- The myelodysplastic syndrome(s): a perspective and review highlighting current controversies (Q35044582) (← links)
- Gene silencing of the p15/INK4B cell-cycle inhibitor by hypermethylation: an early or later epigenetic alteration in myelodysplastic syndromes? (Q35217405) (← links)
- Epigenetic targets in hematopoietic malignancies (Q35551110) (← links)
- Inhibitors of DNA methylation in the treatment of hematological malignancies and MDS. (Q35571293) (← links)
- Distinct association between aberrant methylation of Wnt inhibitors and genetic alterations in acute myeloid leukaemia (Q35653963) (← links)
- Targeting the Sonic Hedgehog-Gli1 Pathway as a Potential New Therapeutic Strategy for Myelodysplastic Syndromes (Q35758737) (← links)
- Epigenetic inactivation of tumor suppressor genes in hematologic malignancies (Q35916788) (← links)
- A critical appraisal of tools available for monitoring epigenetic changes in clinical samples from patients with myeloid malignancies (Q36216230) (← links)
- Quantitative Detection of ID4 Gene Aberrant Methylation in the Differentiation of Myelodysplastic Syndrome from Aplastic Anemia (Q36477232) (← links)
- Digging deep into "dirty" drugs - modulation of the methylation machinery (Q36523796) (← links)
- The role of tumor suppressor p15Ink4b in the regulation of hematopoietic progenitor cell fate (Q36566573) (← links)
- Treatment of acute myeloid leukemia with 20-30% bone marrow blasts (Q36934199) (← links)
- DNA methylation: its role in cancer development and therapy (Q36986433) (← links)
- Models of granulocyte DNA structure are highly predictive of myelodysplastic syndrome (Q37415850) (← links)
- CDK/CCN and CDKI alterations for cancer prognosis and therapeutic predictivity (Q37586623) (← links)
- Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS). (Q37665288) (← links)
- DNA methylation detection using MS-qFRET, a quantum dot-based nanoassay (Q37723600) (← links)
- Stem cells and the aging hematopoietic system (Q37774767) (← links)
- Epigenetic Alterations as Cancer Diagnostic, Prognostic, and Predictive Biomarkers (Q37798947) (← links)
- Myelodysplastic syndromes: an update on molecular pathology. (Q37800283) (← links)
- Epigenetic aspects of MDS and its molecular targeted therapy (Q38051195) (← links)
- Role of epigenetics in chronic myeloid leukemia (Q38072315) (← links)
- p15Ink4b Functions in determining hematopoietic cell fates: implications for its role as a tumor suppressor (Q38081010) (← links)
- -7/7q- syndrome in myeloid-lineage hematopoietic malignancies: attempts to understand this complex disease entity (Q38226741) (← links)
- Reactivating aberrantly hypermethylated p15 gene in leukemic T cells by a phenylhexyl isothiocyanate mediated inter-active mechanism on DNA and chromatin (Q39626369) (← links)
- Azacytidine (Vidaza(R)) in the treatment of myelodysplastic syndromes (Q41980293) (← links)
- Longitudinal Analysis of DNA Methylation in CD34+ Hematopoietic Progenitors in Myelodysplastic Syndrome (Q42923596) (← links)
- Expression and methylation status of the FHIT gene in acute myeloid leukemia and myelodysplastic syndrome (Q46497555) (← links)
- Utility of 5-Methylcytosine Immunohistochemical Staining to Assess Global DNA Methylation and Its Prognostic Impact in MDS Patients (Q47235355) (← links)
- Oxidative stress levels are correlated with P15 and P16 gene promoter methylation in myelodysplastic syndrome patients (Q48186090) (← links)
- Comparison of hypoplastic myelodysplastic syndrome (MDS) with normo-/hypercellular MDS by International Prognostic Scoring System, cytogenetic and genetic studies. (Q53509758) (← links)
- Concomitant aberrant methylation of p15 and MGMT genes in acute myeloid leukemia: association with a particular immunophenotype of blast cells. (Q54301888) (← links)
- Brief report: Loss of p15Ink4b accelerates development of myeloid neoplasms in Nup98-HoxD13 transgenic mice. (Q54383073) (← links)
- Methylation of p15INK4B is common, is associated with deletion of genes on chromosome arm 7q and predicts a poor prognosis in therapy-related myelodysplasia and acute myeloid leukemia. (Q54755048) (← links)
- Aberrant methylation and impaired expression of the p15(INK4b) cell cycle regulatory gene in chronic myelomonocytic leukemia (CMML). (Q54773230) (← links)
- From cellular morphology to molecular and epigenetic anomalies of myelodysplastic syndromes (Q57283873) (← links)
- High methylation of the 4-aminobutyrate aminotransferase gene predicts a poor prognosis in patients with myelodysplastic syndrome (Q61452782) (← links)
- SOCS1 methylation in patients with newly diagnosed acute myeloid leukemia (Q73420594) (← links)
- Aberrant DNA methylation of the Src kinase Hck, but not of Lyn, in Philadelphia chromosome negative acute lymphocytic leukemia (Q79897814) (← links)
- CDKN2B methylation status and isolated chromosome 7 abnormalities predict responses to treatment with 5-azacytidine (Q80568676) (← links)